Gyrus

Corum Advises Retail Consult in Transaction with Gyrus Capital 

Retrieved on: 
Monday, November 21, 2022
Software, Growth, Environment, Electronics, Partnership, Development, Corum, Pharmacy, Telecommunication, POS, Oracle Retail Predictive Application Server (RPAS), Sale, Acquisition, Retail, Oracle, Gyrus

SEATTLE, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Corum Group announces that it has advised its client, Retail Consult, in the sale of a majority stake to the Katalist Group, backed by Gyrus Capital.

Key Points: 
  • SEATTLE, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Corum Group announces that it has advised its client, Retail Consult, in the sale of a majority stake to the Katalist Group, backed by Gyrus Capital.
  • Retail Consult has a team of 300+ consultant experts in retail and in Oracle.
  • Retail Consult is a leading IT consulting firm focused on digital transformation for the retail industry.
  • Retail Consult serves clients across a range of retail segments including fashion, grocery, pharmacy, do it yourself, telecommunications, and electronics.

Essential Pharma strengthens its global operating platform in preparation for next stage of growth

Retrieved on: 
Thursday, August 25, 2022
Pharmaceutical distribution, GDP, CEO, MIA, Health, Union, GMP, History, Risk, Acquisition, Growth, Good manufacturing practice, Patient, Pharmaceutical industry, Fine chemical, EU, Gyrus

These approvals strengthen the company's geographical expansion, improve its operational efficiencies, and enhance its offering as a global business partner.

Key Points: 
  • These approvals strengthen the company's geographical expansion, improve its operational efficiencies, and enhance its offering as a global business partner.
  • Essential Pharma is an international speciality pharmaceutical group dedicated to maintaining access to well-established, "at risk" products essential to patients across multiple therapeutic areas.
  • Essential Pharma operates globallyin more than 20 countries, supplying a portfolio of over 150 essential medicines across multiple therapeutic areas.
  • Essential Pharma's growth strategy is backed by Gyrus Capital, an investment firm dedicated to transformational investments in sectors with long term sustainable growth, including healthcare.

Essential Pharma strengthens its global operating platform in preparation for next stage of growth

Retrieved on: 
Thursday, August 25, 2022
Pharmaceutical distribution, GDP, CEO, MIA, Health, Union, GMP, History, Risk, Acquisition, Growth, Good manufacturing practice, Patient, Pharmaceutical industry, Fine chemical, EU, Gyrus

These approvals strengthen the company's geographical expansion, improve its operational efficiencies, and enhance its offering as a global business partner.

Key Points: 
  • These approvals strengthen the company's geographical expansion, improve its operational efficiencies, and enhance its offering as a global business partner.
  • Essential Pharma is an international speciality pharmaceutical group dedicated to maintaining access to well-established, "at risk" products essential to patients across multiple therapeutic areas.
  • Essential Pharma operates globallyin more than 20 countries, supplying a portfolio of over 150 essential medicines across multiple therapeutic areas.
  • Essential Pharma's growth strategy is backed by Gyrus Capital, an investment firm dedicated to transformational investments in sectors with long term sustainable growth, including healthcare.

LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve Business

Retrieved on: 
Thursday, December 3, 2020
Biotechnology, FDA, Health, Other Health, Surgery, Other Science, Research, Medical devices, General Health, Hospitals, Science, Clinical trials, Cardiology, Medical Supplies, LivaNova, Gyrus, Livanov, LivaNova, Gyrus Capital

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) business.

Key Points: 
  • LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) business.
  • View the full release here: https://www.businesswire.com/news/home/20201203005394/en/
    The LivaNova HV business is a global player in surgical heart valves with world-class products and compelling growth opportunities, said Guy Semmens, Managing Partner at Gyrus Capital.
  • We believe that LivaNova and Gyrus will benefit from this transaction and, that under Gyrus ownership, the HV business will thrive and grow, said Damien McDonald, Chief Executive Officer of LivaNova.
  • Until the closing, LivaNova will operate HV in the normal course of business, with the HV business and Gyrus remaining separate entities.

Online Gaming Addiction in Men Affects Brain's Impulse Control

Retrieved on: 
Wednesday, November 28, 2018
Brain, Frontal lobe, Gyri, Cerebrum, Behavioral addiction, Psychiatric diagnosis, Frontal gyrus, Gaming disorder, Gyrus, Superior frontal gyrus

Internet gaming disorder (IGD) is a condition characterized by compulsive playing of online games to the exclusion of other interests.

Key Points: 
  • Internet gaming disorder (IGD) is a condition characterized by compulsive playing of online games to the exclusion of other interests.
  • In particular, they had lower brain activity in the superior frontal gyrus, an area of the brain's prefrontal lobe that is important to impulse control.
  • "Men have shown lower levels of impulse control in comparison with women, and their impulse control also increases more gradually," she said.
  • It includes social gaming, mobile gaming, and multiplayer gaming, which generates billions of dollars in revenue in the U.S. alone.